Home › Bids
› Blueprint Neurotherapeutics Network (BPN): Small Molecule Dr
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
This bid is closed — responses were due August 18, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This grant opportunity, PAR-25-051, is for the Blueprint Neurotherapeutics Network (BPN) and supports small molecule drug discovery and development for disorders of the nervous system. It utilizes a UG3/UH3 phased award mechanism and includes an optional clinical trial component.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Small Molecule Drug Discovery Services
1
project
$2,000,000.00
$2,000,000.00
Professional Services
Drug Development Services
1
project
$2,000,000.00
$2,000,000.00
Professional Services
Preclinical Research Services
1
project
$1,000,000.00
$1,000,000.00
Professional Services
Clinical Trial Services (Optional)
1
trial
$5,000,000.00
$5,000,000.00
Medical
Estimated Bid Value
$10,000,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds contracting-officer contacts and AI response outlines.